SPOTLIGHT -
Slideshow
Author(s):
Among the clues revealed in 3 recent studies: brain amyloid, saliva biomarkers, and microvascular dysfunction.
Ketamine, TMS Show Promise in Treatment-Resistant Depression in Older Adults
What Will the Future of Alzheimer Disease Treatment Look Like?
Cannabis Use in Senior Patients
Diagnosis and Treatment of Depressive and Memory Problems in Older Adults
FDA Accepts Biologics License Application for Lecanemab-irmb
FDA Grants Breakthrough Device Designation to pTau 217 Blood Test for Alzheimer Disease